Schifano, Fabrizio
Schifano, Fabrizio
Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data
2025-01-01 Chiappini, S.; Mosca, A.; Papanti Pelletier, D. G.; Corkery, J. M.; Guirguis, A.; Arillotta, D.; Martinotti, G.; Schifano, F.
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes
2025-01-01 Mosca, A.; Chiappini, S.; Miuli, A.; Cavallotto, C.; Pettorruso, M.; Martinotti, G.; Schifano, F.
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain
2024-01-01 Montemitro, Chiara; Mosca, Alessio; Chiappini, Stefania; Miuli, Andrea; Schifano, Fabrizio; Montano, Maria Josè Gordillo; Villar, Cristina Merino del; Allegretti, Rita; Marrangone, Carlotta; Di Petta, Gilberto; De Berardis, Domenico; Pettorruso, Mauro; Martinotti, Giovanni
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective
2025-01-01 Chiappini, S.; Guirguis, A.; Schifano, N.; Corkery, J. M.; Semeraro, F.; Mosca, A.; D'Andrea, G.; Duccio Papanti, G.; Arillotta, D.; Floresta, G.; Martinotti, G.; Schifano, F.
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward
2023-01-01 Chiappini, Stefania; Papanti Pelletier, G. Duccio; Vickers-Smith, Rachel; Corkery, John M.; Guirguis, Amira; Martinotti, Giovanni; Schifano, Fabrizio
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach
2024-01-01 Arillotta, Davide; Floresta, Giuseppe; Papanti Pelletier, G. Duccio; Guirguis, Amira; Corkery, John Martin; Martinotti, Giovanni; Schifano, Fabrizio
Focus on ‘Psychiatry and Addiction: A Multi-Faceted Issue’
2025-01-01 Schifano, F.; Martinotti, G.; Scherbaum, N.
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
2023-01-01 Arillotta, Davide; Floresta, Giuseppe; Guirguis, Amira; Corkery, John Martin; Catalani, Valeria; Martinotti, Giovanni; Sensi, Stefano L.; Schifano, Fabrizio
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
2023-01-01 Chiappini, Stefania; Vickers-Smith, Rachel; Harris, Daniel; Papanti Pelletier, G Duccio; Corkery, John Martin; Guirguis, Amira; Martinotti, Giovanni; Sensi, Stefano L; Schifano, Fabrizio
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review
2024-01-01 Chiappini, Stefania; Gramuglia, Pietro Domenico; Mosca, Alessio; Cavallotto, Clara; Miuli, Andrea; Corkery, John Martin; Guirguis, Amira; Schifano, Fabrizio; Martinotti, Giovanni
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances
2024-01-01 Chiappini, Stefania; Vaccaro, Giorgia; Mosca, Alessio; Miuli, Andrea; Stigliano, Gianfranco; Stefanelli, Giulia; Giovannetti, Giulia; Carullo, Rosalba; D'Andrea, Giacomo; Di Carlo, Francesco; Cavallotto, Clara; Pettorruso, Mauro; Di Petta, Gilberto; Corkery, John Martin; Guirguis, Amira; Stair, Jacqueline L.; Martinotti, Giovanni; Fazel, Seena; Schifano, Fabrizio
Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature
2025-01-01 Mosca, A.; Mancusi, G.; Chiappini, S.; Miuli, A.; Cavallotto, C.; Corkery, J. M.; Di Petta, G.; Pasino, A.; Santovito, M. C.; Marrangone, C.; Vicinelli, M. C.; Pettorruso, M.; Martinotti, G.; Schifano, F.
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis
2025-01-01 Mosca, Alessio; Chiappini, Stefania; Mancusi, Gianluca; Miuli, Andrea; Marrangone, Carlotta; Allegretti, Rita; Panichella, Serena; Cavallotto, Clara; Corkery, John Martin; Pettorruso, Mauro; Martinotti, Giovanni; Schifano, Fabrizio
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database
2025-01-01 Chiappini, S.; Orsolini, L.; Corkery, J. M.; Guirguis, A.; Mosca, A.; Arillotta, D.; Martinotti, G.; Schifano, F.
Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT7 and κ‐opioid receptors' molecular interactions and isosteric replacement
2025-01-01 Floresta, Giuseppe; Granzotto, Alberto; Patamia, Vincenzo; Arillotta, Davide; Papanti, Gabriele D.; Guirguis, Amira; Corkery, John M.; Martinotti, Giovanni; Sensi, Stefano L.; Schifano, Fabrizio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data | 2025 | Chiappini, S.; Mosca, A.; Papanti Pelletier, D. G.; Corkery, J. M.; Guirguis, A.; Arillotta, D.; Martinotti, G.; Schifano, F. | |
| Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes | 2025 | Mosca, A.; Chiappini, S.; Miuli, A.; Cavallotto, C.; Pettorruso, M.; Martinotti, G.; Schifano, F. | |
| Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain | 2024 | Montemitro, Chiara; Mosca, Alessio; Chiappini, Stefania; Miuli, Andrea; Schifano, Fabrizio; Montano, Maria Josè Gordillo; Villar, Cristina Merino del; Allegretti, Rita; Marrangone, Carlotta; Di Petta, Gilberto; De Berardis, Domenico; Pettorruso, Mauro; Martinotti, Giovanni | |
| Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective | 2025 | Chiappini, S.; Guirguis, A.; Schifano, N.; Corkery, J. M.; Semeraro, F.; Mosca, A.; D'Andrea, G.; Duccio Papanti, G.; Arillotta, D.; Floresta, G.; Martinotti, G.; Schifano, F. | |
| Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward | 2023 | Chiappini, Stefania; Papanti Pelletier, G. Duccio; Vickers-Smith, Rachel; Corkery, John M.; Guirguis, Amira; Martinotti, Giovanni; Schifano, Fabrizio | |
| Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach | 2024 | Arillotta, Davide; Floresta, Giuseppe; Papanti Pelletier, G. Duccio; Guirguis, Amira; Corkery, John Martin; Martinotti, Giovanni; Schifano, Fabrizio | |
| Focus on ‘Psychiatry and Addiction: A Multi-Faceted Issue’ | 2025 | Schifano, F.; Martinotti, G.; Scherbaum, N. | |
| GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach | 2023 | Arillotta, Davide; Floresta, Giuseppe; Guirguis, Amira; Corkery, John Martin; Catalani, Valeria; Martinotti, Giovanni; Sensi, Stefano L.; Schifano, Fabrizio | |
| Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset | 2023 | Chiappini, Stefania; Vickers-Smith, Rachel; Harris, Daniel; Papanti Pelletier, G Duccio; Corkery, John Martin; Guirguis, Amira; Martinotti, Giovanni; Sensi, Stefano L; Schifano, Fabrizio | |
| Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review | 2024 | Chiappini, Stefania; Gramuglia, Pietro Domenico; Mosca, Alessio; Cavallotto, Clara; Miuli, Andrea; Corkery, John Martin; Guirguis, Amira; Schifano, Fabrizio; Martinotti, Giovanni | |
| New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances | 2024 | Chiappini, Stefania; Vaccaro, Giorgia; Mosca, Alessio; Miuli, Andrea; Stigliano, Gianfranco; Stefanelli, Giulia; Giovannetti, Giulia; Carullo, Rosalba; D'Andrea, Giacomo; Di Carlo, Francesco; Cavallotto, Clara; Pettorruso, Mauro; Di Petta, Gilberto; Corkery, John Martin; Guirguis, Amira; Stair, Jacqueline L.; Martinotti, Giovanni; Fazel, Seena; Schifano, Fabrizio | |
| Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature | 2025 | Mosca, A.; Mancusi, G.; Chiappini, S.; Miuli, A.; Cavallotto, C.; Corkery, J. M.; Di Petta, G.; Pasino, A.; Santovito, M. C.; Marrangone, C.; Vicinelli, M. C.; Pettorruso, M.; Martinotti, G.; Schifano, F. | |
| Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis | 2025 | Mosca, Alessio; Chiappini, Stefania; Mancusi, Gianluca; Miuli, Andrea; Marrangone, Carlotta; Allegretti, Rita; Panichella, Serena; Cavallotto, Clara; Corkery, John Martin; Pettorruso, Mauro; Martinotti, Giovanni; Schifano, Fabrizio | |
| Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database | 2025 | Chiappini, S.; Orsolini, L.; Corkery, J. M.; Guirguis, A.; Mosca, A.; Arillotta, D.; Martinotti, G.; Schifano, F. | |
| Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT7 and κ‐opioid receptors' molecular interactions and isosteric replacement | 2025 | Floresta, Giuseppe; Granzotto, Alberto; Patamia, Vincenzo; Arillotta, Davide; Papanti, Gabriele D.; Guirguis, Amira; Corkery, John M.; Martinotti, Giovanni; Sensi, Stefano L.; Schifano, Fabrizio |